Report Russian Federation - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: Nov 23, 2022

Russian Federation - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact

Single report
Sent by email within 24h (Mon-Fri)

Russian Federation: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the Russian Federation

The Russian human and animal blood market dropped sharply to $X in 2021, waning by -15.8% against the previous year. Overall, the total consumption indicated buoyant growth from 2012 to 2021: its value increased at an average annual rate of +5.4% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption increased by +61.0% against 2015 indices. As a result, consumption attained the peak level of $X, and then dropped rapidly in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the Russian Federation

In value terms, human and animal blood production dropped dramatically to $X in 2021 estimated in export price. In general, production, however, posted a prominent increase. The pace of growth appeared the most rapid in 2020 when the production volume increased by 54%. As a result, production reached the peak level of $X, and then fell sharply in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from the Russian Federation

Human and animal blood exports from Russia skyrocketed to X tons in 2021, increasing by 20% against the previous year. Overall, total exports indicated strong growth from 2012 to 2021: its volume increased at an average annual rate of +7.0% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports decreased by -2.4% against 2019 indices. The pace of growth appeared the most rapid in 2016 when exports increased by 30%. The exports peaked at X tons in 2019; however, from 2020 to 2021, the exports stood at a somewhat lower figure.

In value terms, human and animal blood exports shrank modestly to $X in 2021. Over the period under review, exports showed a buoyant expansion. The most prominent rate of growth was recorded in 2016 with an increase of 58% against the previous year. The exports peaked at $X in 2018; however, from 2019 to 2021, the exports remained at a lower figure.

Exports by Country

Kazakhstan (X tons), Belarus (X tons) and India (X tons) were the main destinations of human and animal blood exports from Russia, with a combined 49% share of total exports. These countries were followed by the UK, Germany, Uzbekistan, Ukraine, Turkey, Tajikistan, Italy, Kyrgyzstan, the Netherlands and Armenia, which together accounted for a further 43%.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Turkey (with a CAGR of +494.4%), while the other leaders experienced more modest paces of growth.

In value terms, Kazakhstan ($X), Belarus ($X) and Uzbekistan ($X) were the largest markets for human and animal blood exported from Russia worldwide, together accounting for 54% of total exports. Ukraine, the UK, the Netherlands, India, Germany, Kyrgyzstan, Armenia, Tajikistan, Italy and Turkey lagged somewhat behind, together accounting for a further 36%.

Among the main countries of destination, the UK, with a CAGR of +298.1%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the average human and animal blood export price amounted to $X per ton, dropping by -18.4% against the previous year. Over the period under review, export price indicated a notable expansion from 2012 to 2021: its price increased at an average annual rate of +3.4% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2016 when the average export price increased by 22% against the previous year. Over the period under review, the average export prices attained the maximum at $X per ton in 2020, and then contracted notably in the following year.

There were significant differences in the average prices for the major export markets. In 2021, the country with the highest price was Ukraine ($X per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Uzbekistan (+8.7%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into the Russian Federation

After two years of decline, overseas purchases of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses increased by 3.1% to X tons in 2021. In general, imports saw a relatively flat trend pattern. The growth pace was the most rapid in 2016 with an increase of 54%. Over the period under review, imports attained the maximum at X tons in 2018; however, from 2019 to 2021, imports failed to regain momentum.

In value terms, human and animal blood imports expanded significantly to $X in 2021. Overall, imports, however, saw a perceptible descent. The most prominent rate of growth was recorded in 2017 with an increase of 20%. Imports peaked at $X in 2013; however, from 2014 to 2021, imports stood at a somewhat lower figure.

Imports by Country

Denmark (X tons), Ukraine (X tons) and the United States (X tons) were the main suppliers of human and animal blood imports to Russia, with a combined 36% share of total imports.

From 2012 to 2021, the biggest increases were in Ukraine (with a CAGR of +35.7%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the UK ($X), Germany ($X) and France ($X) constituted the largest human and animal blood suppliers to Russia, with a combined 40% share of total imports. These countries were followed by Italy, Austria, Ireland, Denmark, Switzerland, Slovenia, the United States, the Netherlands, Ukraine and Bulgaria, which together accounted for a further 54%.

Among the main suppliers, Italy, with a CAGR of +30.4%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2021, rising by 2% against the previous year. In general, the import price, however, showed a pronounced shrinkage. The growth pace was the most rapid in 2017 an increase of 29%. The import price peaked at $X per ton in 2013; however, from 2014 to 2021, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was the UK ($X per ton), while the price for Ukraine ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Austria (+9.4%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform

Base Year Historical Period Forecast Period Units
2021 2007-2021 2022-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the world?
+
The countries with the highest volumes of consumption in 2021 were the United States, China and India, with a combined 51% share of global consumption. These countries were followed by Canada, Japan, Russia, Brazil, France, Spain and the UK, which together accounted for a further 22%.
What are the largest producers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the world?
+
The United States constituted the country with the largest volume of human and animal blood production, accounting for 40% of total volume. Moreover, human and animal blood production in the United States exceeded the figures recorded by the second-largest producer, China, twofold. India ranked third in terms of total production with a 6.9% share.
What are the leading suppliers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses to the Russian Federation?
+
In value terms, the UK, Germany and France were the largest human and animal blood suppliers to Russia, together comprising 40% of total imports. Italy, Austria, Ireland, Denmark, Switzerland, Slovenia, the United States, the Netherlands, Ukraine and Bulgaria lagged somewhat behind, together comprising a further 54%.
What are the leading importers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses from the Russian Federation?
+
In value terms, the largest markets for human and animal blood exported from Russia were Kazakhstan, Belarus and Uzbekistan, with a combined 54% share of total exports. These countries were followed by Ukraine, the UK, the Netherlands, India, Germany, Kyrgyzstan, Armenia, Tajikistan, Italy and Turkey, which together accounted for a further 36%.
What is the average export price for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the Russian Federation?
+
In 2021, the average human and animal blood export price amounted to $28,633 per ton, dropping by -18.4% against the previous year.
What is the average import price for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the Russian Federation?
+
The average human and animal blood import price stood at $103,768 per ton in 2021, rising by 2% against the previous year.

This report provides an in-depth analysis of the market for human and animal blood in the Russian Federation. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
Country coverage:
• Russia

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Trade (exports and imports) in the Russian Federation
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
REPORT DESCRIPTION
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2012–2021
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2012–2021
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

LIST OF TABLES
Table 1:
Key Findings In 2021
Table 2:
Market Volume, In Physical Terms, 2012–2021
Table 3:
Market Value, 2012–2021
Table 4:
Per Capita Consumption In 2007-2021
Table 5:
Imports, In Physical Terms, By Country, 2012–2021
Table 6:
Imports, In Value Terms, By Country, 2012–2021
Table 7:
Import Prices, By Country Of Origin, 2012–2021
Table 8:
Exports, In Physical Terms, By Country, 2012–2021
Table 9:
Exports, In Value Terms, By Country, 2012–2021
Table 10:
Export Prices, By Country Of Destination, 2012–2021
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2021
Figure 2:
Market Value, 2012–2021
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2007-2021
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2007-2021
Figure 5:
Trade Balance, In Physical Terms, 2007-2021
Figure 6:
Trade Balance, In Value Terms, 2007-2021
Figure 7:
Per Capita Consumption, 2007-2021
Figure 8:
Market Forecast To 2030
Figure 9:
Products: Market Size And Growth, By Type
Figure 10:
Products: Average Per Capita Consumption, By Type
Figure 11:
Products: Exports And Growth, By Type
Figure 12:
Products: Export Prices And Growth, By Type
Figure 13:
Production Volume And Growth
Figure 14:
Exports And Growth
Figure 15:
Export Prices And Growth
Figure 16:
Market Size And Growth
Figure 17:
Per Capita Consumption
Figure 18:
Imports And Growth
Figure 19:
Import Prices
Figure 20:
Production, In Physical Terms, 2012–2021
Figure 21:
Production, In Value Terms, 2012–2021
Figure 22:
Imports, In Physical Terms, 2012–2021
Figure 23:
Imports, In Value Terms, 2012–2021
Figure 24:
Imports, In Physical Terms, By Country, 2021
Figure 25:
Imports, In Physical Terms, By Country, 2012–2021
Figure 26:
Imports, In Value Terms, By Country, 2012–2021
Figure 27:
Import Prices, By Country Of Origin, 2012–2021
Figure 28:
Exports, In Physical Terms, 2012–2021
Figure 29:
Exports, In Value Terms, 2012–2021
Figure 30:
Exports, In Physical Terms, By Country, 2021
Figure 31:
Exports, In Physical Terms, By Country, 2012–2021
Figure 32:
Exports, In Value Terms, By Country, 2012–2021
Figure 33:
Export Prices, By Country Of Destination, 2012–2021
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET